Tech Company Financing Transactions

Veran Medical Technologies Funding Round

Veran Medical Technologies, operating out of St. Louis, scored $31 million in funding from Oxford Finance, River Cities Capital Funds and Versant Ventures.

Transaction Overview

Announced On
12/22/2016
Transaction Type
Debt
Venture Equity
Amount
$31,000,000
Round
Undisclosed
Investors

Oxford Finance (Christopher Herr)

River Cities Capital Funds (David Kereiakes)

Versant Ventures (Kirk Nielsen)

Proceeds Purpose
Veran will use proceeds of the financing to accelerate commercialization and innovation of its SPiN Thoracic Navigation System� technology platform.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1908 Innerbelt Business Center Dr.
St. Louis, MO 63114
USA
Email Address
Overview
Veran Medical Technologies is a privately held image-guided medical device company focused on developing the next standard of care for minimally invasive delivery of interventional oncology therapies. Veran provides proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform.
Profile
Veran Medical Technologies LinkedIn Company Profile
Social Media
Veran Medical Technologies Company Twitter Account
Company News
Veran Medical Technologies News
Facebook
Veran Medical Technologies on Facebook
YouTube
Veran Medical Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jason Pesterfield
  Jason Pesterfield LinkedIn Profile  Jason Pesterfield Twitter Account  Jason Pesterfield News  Jason Pesterfield on Facebook
Chief Financial Officer
Kirk Jacquay
  Kirk Jacquay LinkedIn Profile  Kirk Jacquay Twitter Account  Kirk Jacquay News  Kirk Jacquay on Facebook
Chief Technical Officer
Troy Holsing
  Troy Holsing LinkedIn Profile  Troy Holsing Twitter Account  Troy Holsing News  Troy Holsing on Facebook
VP - Marketing
TJ Meyer
  TJ Meyer LinkedIn Profile  TJ Meyer Twitter Account  TJ Meyer News  TJ Meyer on Facebook
VP - Operations
Mark Hunter
  Mark Hunter LinkedIn Profile  Mark Hunter Twitter Account  Mark Hunter News  Mark Hunter on Facebook
VP - Regulatory Affairs
Scott Wrightstone
  Scott Wrightstone LinkedIn Profile  Scott Wrightstone Twitter Account  Scott Wrightstone News  Scott Wrightstone on Facebook
VP - Sales
Ryan Denney
  Ryan Denney LinkedIn Profile  Ryan Denney Twitter Account  Ryan Denney News  Ryan Denney on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/22/2016: Revolution Medicines venture capital transaction
Next: 12/22/2016: Optoro venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary